Potential antiatherogenic mechanisms of ascorbate (vitamin C) and α-tocopherol (vitamin E)

Circulation Research

Volumn 87, Issue 5, 2000, Pages 349-354

  Carr, Anitra C ^a   Zhu, Ben Zhan ^a   Frei, Balz ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Ascorbic acid; Atherosclerosis; Endothelial cells; Low density lipoprotein; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; HUMAN; LEUKOCYTE ADHERENCE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034283054     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.5.349     Document Type: Short Survey

References (66)

1. The role of oxidized lipoproteins in atherogenesis
2. Antioxidants and atherosclerotic heart disease
3. Vitamin E and heart disease: Basic science to clinical intervention trials
4. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans
5. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: Reaction pathways and antioxidant protection
6. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
7. Low density lipoprotein oxidation and its pathobiological significance
8. Tocopherol-mediated peroxidation: The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein
9. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
10. Ascorbate is an outstanding antioxidant in human blood plasma
11. Does vitamin C act as a pro-oxidant under physiological conditions?
12. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells
13. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol
14. Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein
15. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification: Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions
16. Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase
17. Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: Identification as glutaredoxin
18. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation
19. Human atherosclerotic plaque contains both oxidised lipids and relatively large amounts of α-tocopherol and ascorbate
20. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: Implications for atherogenesis
21. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
22. Leukocyte-endothelial cell adhesion: Avenues for therapeutic intervention
23. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers
24. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral L-arginine but not vitamin C
25. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo
26. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking
27. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E
28. α-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells
29. α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells
30. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
31. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro
32. Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells
33. α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells
34. The effects of α-tocopherol supplementation on monocyte function: Decreased lipid oxidation, interleukin 1β secretion, and monocyte adhesion to endothelium
35. Dietary vitamin E supplementation inhibits thromhin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia
36. α-Tocopherol inhibits the respiratory burst in human monocytes: Attenuation of p47(phox) membrane translocation and phosphorylation
37. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
38. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide
39. The L-arginine-nitric oxide pathway
40. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action
41. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
42. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins
43. Recovery by ascorbate of impaired nitric oxide-dependent relaxation resulting from oxidant stress in rat aorta
44. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations
45. Ascorbic acid transport and accumulation in human nentrophils
46. L-ascorbic acid potentiates nitric oxide synthesis in endothelial cells
47. Ascorbic acid enhances endothelial nitric oxide synthase activity by increasing intracellular tetrahydrobiopterin
48. Glutathione-ascorbic acid antioxidant system in animals
49. Biochemistry of nitric oxide and its redox-activated forms
50. Role of ascorbic acid in the metabolism of S-nitroso-glutathione
51. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits
52. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation
53. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits
54. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
55. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both
56. Additional benefit of vitamin E supplementation to simva-statin therapy on vasoreactivity of the bracbial artery of hypercholesterolemic men
57. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia
58. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults
59. Effects of vitamin E on endothelial function in men after myocardial infarction
60. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans
61. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
62. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: Improvement with antioxidant vitamin therapy
63. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal
64. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia
65. The pecking order of free radicals and antioxidants: Lipid peroxidation, α-tocopherol, and ascorbate
66. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature: Evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin